About us
The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients.
Projects
Participation
Events
Press
Contact
Breadcrumbs
Avoidable gaps in knowledge - why do they occur? (German version)
PD Dr. med. Jörg Meerpohl
Barriers and obstacles on the way to more evidence in emergency care: experience from the Triple-A study (German version)
Felicitas Geier
The SPACE-2 study on the treatment of asymptomatic carotid artery stenosis: What were the reasons for its failure? (German version)
Prof. Dr. med. Dipl. Inf. (FH) Peter Arthur Ringleb
When can opiates be discontinued? Challenges and obstacles on the way towards an evidence-based answer (German version)
Prof. Dr. med. Annette Becker
The perspective of a funding institution: Why studies can fail (German version)
Dr. rer. nat. Franz Kohlhuber
The perspective of the industry: Why studies can fail (German version)
Klaus Weber
Germany – a special case? The general framework for clinical studies in Europe (examples) (German version)
Prof. Dr. Christian Ohmann
From CIMT to HOMECIMT: Why a study succeeded (German version)
Dr. med. Anne Barzel
FANCY: Success factors in a study on corneal transplantation (German version)
Prof. Dr. med. Daniel Böhringer
Clinical studies in Germany: Do we need to do more? (German version)
Dr. med. Jürgen Grebe
Programme IQWiG Autumn Symposium 2016
Short biographies of the speakers (German)
